In silico multiscale cardiovascular modeling for a patient-specific data
In silico multiscale modeling gives opportunity for a patient-specific model in order to improve the quality of prediction for the disease progression into life-threatening events that need to be treated accordingly. In this special session authors will present advanced research support tools for cardiovascular disease characterization, virtual stent deployment, carotid and coronary artery plaque modeling, cardiomyopathy disease simulation, drug efficacy etc. In silico modeling will reduce invention-to-market lead-time yielding safer and more cost-effective devices that minimize the need for animal and human testing.
This Special session will collect papers for in silico multiscale modeling that would take into consideration comprehensive list of patient specific features (genetic, biological, pharmacologic, clinical, imaging and patient specific cellular aspects) capable of optimizing and testing medical treatment strategy of drugs and medical devices with the purpose of maximizing positive therapeutic outcome, avoiding adverse effects, avoiding drug interactions, preventing sudden cardiac death, shortening time between the drug treatment commencement and the desired result.
|Paper Submission Deadline||August 5, 2019|
|Paper Notification||August 20, 2019|
|Paper Camera-Ready Paper Submission||August 30, 2019|
Nenad D. Filipovic
Nenad D. Filipovic is full Professor at Faculty of Engineering, Head of Center for Bioengineering and Rector of University of Kragujevac, Serbia. He was Research Associate at Harvard School of Public Health in Boston, USA. His research interests are in the area of biomedical engineering, cardiovascular disease, fluid-structure interaction, biomechanics, multi-scale modeling, data mining, software engineering, parallel computing, computational chemistry and bioprocess modeling. He is author and co-author 20 textbooks and 9 monographies, over 250 publications in peer review journals and over 10 software for modeling with finite element method and discrete methods from biofluid and biosolid mechanics and multiphysics. He also leads a number of national and international projects in EU and US in area of bioengineering and software development.